JP2021500854A5 - - Google Patents

Download PDF

Info

Publication number
JP2021500854A5
JP2021500854A5 JP2020513341A JP2020513341A JP2021500854A5 JP 2021500854 A5 JP2021500854 A5 JP 2021500854A5 JP 2020513341 A JP2020513341 A JP 2020513341A JP 2020513341 A JP2020513341 A JP 2020513341A JP 2021500854 A5 JP2021500854 A5 JP 2021500854A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
acid sequence
scfv
igg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020513341A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021500854A (ja
JP7319250B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/049808 external-priority patent/WO2019051132A1/en
Publication of JP2021500854A publication Critical patent/JP2021500854A/ja
Publication of JP2021500854A5 publication Critical patent/JP2021500854A5/ja
Priority to JP2023075590A priority Critical patent/JP2023087005A/ja
Application granted granted Critical
Publication of JP7319250B2 publication Critical patent/JP7319250B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020513341A 2017-09-06 2018-09-06 Ｓｔｒｅｐ－タグ特異的結合タンパク質およびその使用 Active JP7319250B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023075590A JP2023087005A (ja) 2017-09-06 2023-05-01 Ｓｔｒｅｐ－タグ特異的結合タンパク質およびその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762555017P 2017-09-06 2017-09-06
US62/555,017 2017-09-06
PCT/US2018/049808 WO2019051132A1 (en) 2017-09-06 2018-09-06 BINDING PROTEINS SPECIFIC TO A STREP LABEL AND USES THEREOF

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023075590A Division JP2023087005A (ja) 2017-09-06 2023-05-01 Ｓｔｒｅｐ－タグ特異的結合タンパク質およびその使用

Publications (3)

Publication Number Publication Date
JP2021500854A JP2021500854A (ja) 2021-01-14
JP2021500854A5 true JP2021500854A5 (enExample) 2021-10-14
JP7319250B2 JP7319250B2 (ja) 2023-08-01

Family

ID=63714039

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020513341A Active JP7319250B2 (ja) 2017-09-06 2018-09-06 Ｓｔｒｅｐ－タグ特異的結合タンパク質およびその使用
JP2023075590A Pending JP2023087005A (ja) 2017-09-06 2023-05-01 Ｓｔｒｅｐ－タグ特異的結合タンパク質およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023075590A Pending JP2023087005A (ja) 2017-09-06 2023-05-01 Ｓｔｒｅｐ－タグ特異的結合タンパク質およびその使用

Country Status (8)

Country Link
US (1) US20200262894A1 (enExample)
EP (1) EP3678689A1 (enExample)
JP (2) JP7319250B2 (enExample)
KR (1) KR20200041377A (enExample)
CN (1) CN111065409A (enExample)
AU (1) AU2018327229A1 (enExample)
CA (1) CA3072908A1 (enExample)
WO (1) WO2019051132A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ759969A (en) 2013-12-20 2022-12-23 Fred Hutchinson Cancer Center Tagged chimeric effector molecules and receptors thereof
EP3288570A4 (en) 2015-04-29 2018-11-21 Fred Hutchinson Cancer Research Center Modified stem cells and uses thereof
CN111051349A (zh) * 2017-09-06 2020-04-21 弗雷德哈钦森癌症研究中心 Strep-tag特异性嵌合受体及其用途
CN112250767B (zh) * 2020-12-08 2021-05-18 北京艺妙神州医药科技有限公司 一种结合Strep-Tag II标签的抗体及其应用
KR20240007203A (ko) * 2021-05-13 2024-01-16 고에키 자이단 호징 고베 이료 산교 도시 스이신 기코 염증성 질환을 치료 또는 예방하기 위한 항-인간 pd-1 작용제 항체 및 이를 함유하는 의약 조성물
CN118119847A (zh) * 2021-10-08 2024-05-31 泰贝乐医疗科技有限公司 用于检测cdh17的方法和组合物
JP2025516377A (ja) * 2022-05-09 2025-05-27 杭州微諾邁博生物科技有限公司 多重特異性抗体を含む治療薬及び腫瘍治療におけるその使用
TW202617750A (zh) * 2024-07-10 2026-05-01 美商安吉利斯治療學公司 包含表位與多肽的組成物及方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283173A (en) 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
US7067318B2 (en) 1995-06-07 2006-06-27 The Regents Of The University Of Michigan Methods for transfecting T cells
AU2472400A (en) 1998-10-20 2000-05-08 City Of Hope CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies
US6946292B2 (en) 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
DE10113776B4 (de) 2001-03-21 2012-08-09 "Iba Gmbh" Isoliertes streptavidinbindendes, kompetitiv eluierbares Peptid, dieses umfassendes Fusionspeptid, dafür codierende Nukleinsäure, Expressionsvektor, Verfahren zur Herstellung eines rekombinanten Fusionsproteins und Verfahren zum Nachweis und/oder zur Gewinnung des Fusionsproteins
US7070995B2 (en) 2001-04-11 2006-07-04 City Of Hope CE7-specific redirected immune cells
US7514537B2 (en) 2001-04-30 2009-04-07 City Of Hope Chimeric immunoreceptor useful in treating human gliomas
WO2006076678A2 (en) 2005-01-13 2006-07-20 The Johns Hopkins University Prostate stem cell antigen vaccines and uses thereof
WO2008042814A2 (en) 2006-09-29 2008-04-10 California Institute Of Technology Mart-1 t cell receptors
KR101319499B1 (ko) 2008-02-22 2013-10-17 엘지디스플레이 주식회사 화학적 자기조립 방법을 이용한 나노선 혹은탄소나노튜브의 적층 및 패턴형성 방법과, 이를 적용한액정표시장치의 제조방법
CA2735456C (en) 2008-08-26 2021-11-16 City Of Hope Method and compositions for enhanced anti-tumor effector functioning of t cells
EP2210903A1 (en) 2009-01-21 2010-07-28 Monoclonal Antibodies Therapeutics Anti-CD160 monoclonal antibodies and uses thereof
JP5812418B2 (ja) * 2009-04-17 2015-11-11 イムナス・ファーマ株式会社 Ａβオリゴマーに特異的に結合する抗体およびその利用
EP2258719A1 (en) 2009-05-19 2010-12-08 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Multiple target T cell receptor
LT2884999T (lt) 2012-08-20 2021-04-12 Fred Hutchinson Cancer Research Center Ląstelinės imunoterapijos būdas ir kompozicijos
AU2013361275B2 (en) 2012-12-19 2016-11-24 Amplimmune, Inc. Anti-human B7-H4 antibodies and their uses
EP2871189A1 (en) * 2013-11-07 2015-05-13 Institut Pasteur High-affinity monoclonal anti-strep-tag antibody
NZ759969A (en) * 2013-12-20 2022-12-23 Fred Hutchinson Cancer Center Tagged chimeric effector molecules and receptors thereof
WO2016040441A1 (en) * 2014-09-09 2016-03-17 Unum Therapeutics Chimeric receptors and uses thereof in immune therapy
TW201625689A (zh) 2014-09-12 2016-07-16 建南德克公司 抗－ｂ７－ｈ４抗體及免疫結合物
RU2017115315A (ru) 2014-10-03 2018-11-08 Дана-Фарбер Кэнсер Инститьют, Инк. Антитела к рецептору глюкокортикоид-индуцированного фактора некроза опухоли (gitr) и способы их применения
IL254039B2 (en) 2015-02-19 2023-12-01 Compugen Ltd Anti-pvrig antibodies and methods of use
JO3620B1 (ar) 2015-08-05 2020-08-27 Amgen Res Munich Gmbh مثبطات نقطة فحص مناعية للاستخدام في علاج سرطانات محمولة عبر الدم

Similar Documents

Publication Publication Date Title
JP7097636B2 (ja) 抗Ｈｅｒ２ナノボディ及びそのコード序列と用途
US12180296B2 (en) Cross species single domain antibodies targeting mesothelin for treating solid tumors
CN114634569B (zh) 高亲和力b7-h6抗体和抗体片段
US9200078B2 (en) Antibodies against prostate-specific stem cell antigen and use thereof
AU2017293450B2 (en) Humanized antibodies transmigrating the blood-brain barrier and uses thereof
AU2022434181B2 (en) Anti-TSLP nanobodies and their applications
US12122843B2 (en) High affinity monoclonal antibodies targeting glypican-1 and methods of use
JP2012518425A5 (enExample)
JP2017510251A (ja) 抗ＳＩＲＰα抗体および二重特異性マクロファージ増強抗体
JP2017519501A5 (enExample)
CN112552408B (zh) 靶向caix抗原的纳米抗体及其应用
JP7851303B2 (ja) ヒトｃｄ３イプシロンに結合する新規なヒト抗体
JP2017526339A5 (enExample)
HRP20140502T1 (hr) Humanizirana anti-cxcr4 antitijela za lijeäśenje karcinoma
CN114729031A (zh) 抗溶瘤病毒抗原抗体及其使用方法
CN108178799B (zh) 一种抗ca125糖类抗原的纳米抗体及其应用
CN111065409A (zh) Strep-tag特异性结合蛋白及其用途
JP2014515600A5 (enExample)
CN118043357A (zh) Cd3靶向抗体及其用途
CN119306837B (zh) 一种抗cd276的纳米抗体及其应用
US10906973B2 (en) Antibody variants transmigrating the blood-brain barrier and uses thereof
JP7688941B2 (ja) Ｃｄ８結合ポリペプチドおよびその使用
JP2022518478A5 (enExample)
JP2025508984A5 (enExample)
WO2023116781A1 (zh) 一种新型pd1单域抗体的开发